Literature DB >> 19406267

Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation.

Takashi Koyama1, Yukio Sekiguchi, Hiroshi Tada, Takanori Arimoto, Hiro Yamasaki, Kenji Kuroki, Takeshi Machino, Kazuko Tajiri, Xu Dong Zhu, Miyako Kanemoto, Aiko Sugiyasu, Keisuke Kuga, Kazutaka Aonuma.   

Abstract

Atrial fibrillation (AF) recurrences after catheter ablation are common within the first month after AF ablation, and inflammatory processes may be related to AF genesis. This study aimed to clarify the relation between inflammatory processes and recurrence of AF after ablation and to characterize AF recurring within 3 days after ablation (immediate AF recurrence).The study included 186 patients with drug-refractory paroxysmal AF who underwent extensive pulmonary vein isolation. Body temperature and C-reactive protein level were measured before and consecutively on the first 3 days after ablation. Signs of pericarditis or atrial arrhythmias within 3 days after ablation were also monitored. Forty-five patients (24%) had immediate AF recurrence (immediate-AF-recurrence group), 27 (14%) had early recurrence 4 to 30 days after ablation (early-AF-recurrence group), and the remaining 114 (61%) had no AF recurrence within 1 month after ablation (no-AF-recurrence group). Increases in body temperature and C-reactive protein level from baseline in the immediate-AF-recurrence group were the highest among the 3 groups, and signs of pericarditis were observed in 15 of the 45 patients (33%) in the immediate-AF-recurrence group. Atrial premature contractions and nonsustained AF occurred most frequently in the early-AF-recurrence group. After 6-month follow-up, the AF-free rate was greater in the immediate-AF-recurrence group (76%) than in the early-AF-recurrence group (30%). In conclusion, immediate AF recurrence has an apparently different mechanism and impact on midterm outcomes than does early AF recurrence. Acute inflammatory changes after ablation may be responsible for immediate AF recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406267     DOI: 10.1016/j.amjcard.2009.01.010

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Clinical significance of the timing of early recurrence of atrial arrhythmia after pulmonary vein isolation: a two-institution clinical study.

Authors:  Yosuke Murase; Yasuya Inden; Hajime Imai; Seifuku Kyo; Satoshi Yanagisawa; Aya Fujii; Yusuke Sakamoto; Toshiro Tomomatsu; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

Review 2.  Role of Inflammation in Early AF Recurrence After PV Isolation.

Authors:  Rupa Bala
Journal:  J Atr Fibrillation       Date:  2009-10-01

3.  Is an elevated burden of antiarrhythmic drug (AAD) side-effects the unavoidable price to be traded for a durable suppression of AF relapses in ablated patients? The weaknesses and risks of the AAD suppression algorithm used by current models of AF secondary prevention after catheter ablation.

Authors:  Renato De Vecchis
Journal:  Eur J Clin Pharmacol       Date:  2019-01-29       Impact factor: 2.953

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Peri-procedural Corticosteroid Use in Improving Outcomes Following Atrial Fibrillation Ablation: Back to Square One?

Authors:  Rakesh Gopinathannair
Journal:  J Atr Fibrillation       Date:  2017-02-28

6.  IntravenousCorticosteroid Use Is Associated With Reduced Early Recurrence of Atrial Fibrillation Immediately Following Radiofrequency Catheter Ablation.

Authors:  Nitesh A Sood; Guru M Krishnan; Craig I Coleman; Jeffrey Kluger; Moise Anglade; Christopher A Clyne
Journal:  J Atr Fibrillation       Date:  2011-09-30

7.  Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation.

Authors:  Masaharu Masuda; Hiroya Mizuno; Yukihiro Enchi; Hitoshi Minamiguchi; Shozo Konishi; Tomohito Ohtani; Osamu Yamaguchi; Yuji Okuyama; Shinsuke Nanto; Yasushi Sakata
Journal:  J Interv Card Electrophysiol       Date:  2015-06-28       Impact factor: 1.900

8.  Early Recurrences During the Blanking Period after Atrial Fibrillation Ablation.

Authors:  Jackson J Liang; Sanjay Dixit
Journal:  J Atr Fibrillation       Date:  2018-02-28

9.  Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation.

Authors:  Celestino Sardu; Gaetano Santulli; Matteo Santamaria; Michelangela Barbieri; Cosimo Sacra; Pasquale Paolisso; Fabio D'Amico; Nicola Testa; Igor Caporaso; Giuseppe Paolisso; Raffaele Marfella; Maria Rosaria Rizzo
Journal:  Am J Cardiol       Date:  2017-02-10       Impact factor: 2.778

10.  What Does The Blanking Period Blank?

Authors:  M A Mariani; A Pozzoli; Ge De Maat; O R Alfieri; S Benussi
Journal:  J Atr Fibrillation       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.